TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
31.51
-0.24 (-0.76%)
At close: Mar 30, 2026, 4:00 PM EDT
31.11
-0.40 (-1.27%)
Pre-market: Mar 31, 2026, 6:37 AM EDT
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $4.65 billion as of March 31, 2026. Its market cap has decreased by -20.06% in one year.
Market Cap
4.65B
Enterprise Value
4.77B
1-Year Change
-20.06%
Ranking
Category
Stock Price
$31.51
Market Cap Chart
Since December 1, 1998, TG Therapeutics's market cap has increased from $34.90M to $4.65B, an increase of 13,233.19%. That is a compound annual growth rate of 19.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 5.07B | 7.13% |
| Dec 31, 2025 | 4.73B | 1.01% |
| Dec 31, 2024 | 4.69B | 81.18% |
| Dec 29, 2023 | 2.59B | 50.41% |
| Dec 30, 2022 | 1.72B | -36.69% |
| Dec 31, 2021 | 2.72B | -60.29% |
| Dec 31, 2020 | 6.84B | 518.96% |
| Dec 31, 2019 | 1.11B | 225.13% |
| Dec 31, 2018 | 339.90M | -41.33% |
| Dec 29, 2017 | 579.30M | 127.62% |
| Dec 30, 2016 | 254.50M | -59.38% |
| Dec 31, 2015 | 626.60M | -10.02% |
| Dec 31, 2014 | 696.40M | 433.23% |
| Dec 31, 2013 | 130.60M | 43.20% |
| Dec 31, 2012 | 91.20M | 91,100.00% |
| Dec 30, 2011 | 100.00K | -95.45% |
| Dec 31, 2010 | 2.20M | -58.49% |
| Dec 31, 2009 | 5.30M | 783.33% |
| Dec 31, 2008 | 600.00K | -90.63% |
| Dec 31, 2007 | 6.40M | -86.18% |
| Dec 29, 2006 | 46.30M | -38.35% |
| Dec 30, 2005 | 75.10M | 181.27% |
| Dec 31, 2004 | 26.70M | -27.64% |
| Dec 31, 2003 | 36.90M | 623.53% |
| Dec 31, 2002 | 5.10M | -49.50% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 5.20B |
| Rhythm Pharmaceuticals | 5.18B |
| Celcuity | 5.12B |
| Scholar Rock Holding | 4.89B |
| Immunovant | 4.88B |
| Caris Life Sciences | 4.79B |
| Erasca | 4.65B |
| Amicus Therapeutics | 4.52B |